Expression of functional PACAP/VIP receptors in human prostate cancer and healthy tissue. 2003

M Olga García-Fernández, and Rosa M Solano, and María J Carmena, and Rebeca Busto, and Guillermo Bodega, and Antonio Ruíz-Villaespesa, and Juan C Prieto, and Manuel Sánchez-Chapado
Department of Biochemistry and Molecular Biology, University of Alcalá, E-28871 Alcalá de Henares, Spain.

Vasoactive intestinal peptide (VIP) is involved in prostate cell proliferation and function. VIP and pituitary adenylate cyclase-activating peptide (PACAP) are similarly recognized by VPAC(1)/VPAC(2) receptors whereas PACAP binds with higher affinity than VIP to PAC(1) receptor. Here we systematically studied the presence and distribution of functional PAC(1), VPAC(1) and VPAC(2) receptors in human normal and malignant prostate tissue. Functional PACAP/VIP receptors were detected in normal and malignant prostate by adenylyl cyclase stimulation with PACAP-27/38 and VIP. RT-PCR experiments showed PAC(1) (various isoforms due to alternative splicing), VPAC(1) and VPAC(2) receptor expression at the mRNA level, whereas Western blots found the three receptor protein classes in normal and pathological conditions. No conclusive differences could be established when comparing control and cancer tissue samples. Immunohistochemistry showed a weaker immunostaining in tumoral than in normal epithelial cells for the three receptor subtypes. In conclusion, we demonstrate the expression of functional PAC(1), VPAC(1) and VPAC(2) receptors in human prostate as well as its maintenance after malignant transformation.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009479 Neuropeptides Peptides released by NEURONS as intercellular messengers. Many neuropeptides are also hormones released by non-neuronal cells. Neuropeptide
D011467 Prostate A gland in males that surrounds the neck of the URINARY BLADDER and the URETHRA. It secretes a substance that liquefies coagulated semen. It is situated in the pelvic cavity behind the lower part of the PUBIC SYMPHYSIS, above the deep layer of the triangular ligament, and rests upon the RECTUM. Prostates
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D011979 Receptors, Pituitary Hormone Cell surface proteins that bind pituitary hormones with high affinity and trigger intracellular changes influencing the behavior of cells. Since many pituitary hormones are also released by neurons as neurotransmitters, these receptors are also found in the nervous system. Pituitary Hormone Receptors,Receptors, Pituitary Hormones,Pituitary Hormones Receptors
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

M Olga García-Fernández, and Rosa M Solano, and María J Carmena, and Rebeca Busto, and Guillermo Bodega, and Antonio Ruíz-Villaespesa, and Juan C Prieto, and Manuel Sánchez-Chapado
July 2006, Annals of the New York Academy of Sciences,
M Olga García-Fernández, and Rosa M Solano, and María J Carmena, and Rebeca Busto, and Guillermo Bodega, and Antonio Ruíz-Villaespesa, and Juan C Prieto, and Manuel Sánchez-Chapado
July 1999, The American journal of physiology,
M Olga García-Fernández, and Rosa M Solano, and María J Carmena, and Rebeca Busto, and Guillermo Bodega, and Antonio Ruíz-Villaespesa, and Juan C Prieto, and Manuel Sánchez-Chapado
February 1998, Brain research. Molecular brain research,
M Olga García-Fernández, and Rosa M Solano, and María J Carmena, and Rebeca Busto, and Guillermo Bodega, and Antonio Ruíz-Villaespesa, and Juan C Prieto, and Manuel Sánchez-Chapado
March 2004, Cancer letters,
M Olga García-Fernández, and Rosa M Solano, and María J Carmena, and Rebeca Busto, and Guillermo Bodega, and Antonio Ruíz-Villaespesa, and Juan C Prieto, and Manuel Sánchez-Chapado
January 1997, Peptides,
M Olga García-Fernández, and Rosa M Solano, and María J Carmena, and Rebeca Busto, and Guillermo Bodega, and Antonio Ruíz-Villaespesa, and Juan C Prieto, and Manuel Sánchez-Chapado
January 2000, Annals of the New York Academy of Sciences,
M Olga García-Fernández, and Rosa M Solano, and María J Carmena, and Rebeca Busto, and Guillermo Bodega, and Antonio Ruíz-Villaespesa, and Juan C Prieto, and Manuel Sánchez-Chapado
July 2019, Journal of molecular neuroscience : MN,
M Olga García-Fernández, and Rosa M Solano, and María J Carmena, and Rebeca Busto, and Guillermo Bodega, and Antonio Ruíz-Villaespesa, and Juan C Prieto, and Manuel Sánchez-Chapado
August 1997, Regulatory peptides,
M Olga García-Fernández, and Rosa M Solano, and María J Carmena, and Rebeca Busto, and Guillermo Bodega, and Antonio Ruíz-Villaespesa, and Juan C Prieto, and Manuel Sánchez-Chapado
December 2001, Peptides,
M Olga García-Fernández, and Rosa M Solano, and María J Carmena, and Rebeca Busto, and Guillermo Bodega, and Antonio Ruíz-Villaespesa, and Juan C Prieto, and Manuel Sánchez-Chapado
January 2000, Annals of the New York Academy of Sciences,
Copied contents to your clipboard!